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Abstract
Th1 cell-mediated immune responses at the site of active infection are important to restrict the growth of M.tuberculosis
(MTB) and for the spontaneous resolution of patients with tuberculous pleurisy (TBP). In the present study, we found that
without any stimulation, CD4
+ T cells in pleural fluid cells (PFCs) from patients with TBP expressed significantly higher levels
of CD69 than PBMCs from patients with tuberculosis (TB) or healthy donors. CD4
+CD69
+ T cells expressed T-bet and IL-
12Rb2. After stimulation with MTB-specific antigens, CD4
+CD69
+ T cells expressed significantly higher levels of IFN-c, IL-2
and TNF-a than CD4
+CD69
2 T cells, demonstrating that CD4
+CD69
+ T cells were MTB-specific Th1 cells. In addition,
CD4
+CD69
+ T cells were mostly polyfunctional Th1 cells that simultaneously produced IFN-c, IL-2, TNF-a and displayed an
effector or effector memory phenotype (CD45RA
2CCR7
2CD62L
2CD27
2). Moreover, the percentages of CD4
+CD69
+ T cells
were significantly and positively correlated with polyfunctional T cells. Interestingly, sorted CD4
+CD69
+ but not CD4
+CD69
2
fractions by flow cytometry produced IFN-c, IL-2 and TNF-a that were significantly regulated by CD4
+CD25
+ Treg cells.
Taken together, based on the expression of CD69, we found a direct quantitative and qualitative method to detect and
evaluate the in vivo generated MTB-specific polyfunctional CD4
+ T cells in PFCs from patients with TBP. This method can be
used for the potential diagnosis and enrichment or isolation of MTB-specific Th1 cells in the investigations.
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Introduction
Tuberculous pleurisy (TBP) is characterized by an intense
chronic accumulation of inflammatory cells at the disease site,
including the activation of Th1 cells and their preferential
recruitment to the affected areas [1,2]. However, TBP remains
difficult to identify despite numerous diagnostic tools [3].
Currently, the definite diagnosis of tuberculosis (TB) pleural
effusions depends on the demonstration of acid-fast bacilli in the
sputum, pleural fluid, or pleural biopsy specimens [4]. Moreover,
high levels of IFN-c are detected in tuberculosis pleural fluid [5,6].
Therefore, measurement of IFN-c in the pleural fluid has also
gained wide acceptance in the diagnosis of TB pleural effusions
[7]. However, these assays did not provide information regarding
antigen-responsive cells. An abundance of immunocompetent cells
in the pleural effusion provides investigators with a good model to
study the correlates of a protective immune response at the site of
infection. The enrichment of Th1 cells in pleural fluid has been
previously documented [8]. However, detailed phenotypic and
functional characterizations for these cells are still unknown.
The BCG vaccine is an attenuated strain of Mycobacterium bovis
and includes loss of the esx 1 locus, which encodes two family
members, culture filtrate protein of 10 kDa (CFP-10) and early
secretory antigenic target 6 (ESAT-6). These antigens have an
important diagnostic role in distinguishing BCG vaccination from
MTB infection [9–13]. Although ESAT-6 and CFP-10 contain
numerous potential T cell epitopes, the immune response during
infection is often focused toward a few immunodominant epitopes.
In the present study, we selected the six most dominant peptides
identified in ESAT-6 and CFP-10, as reported to be frequently
recognized by subjects in Indian, European, Cambodian, and
Middle Eastern cohorts with both latent and active TB [14–19].
It has already been demonstrated that T-lymphocytes in the
lungs, both in normal individuals and in those with granulomatous
disease, are almost entirely CD45RO
+ memory T cells and express
both early- and late-activation markers, such as CD69 and CD29
respectively [20]. Previous data have demonstrated that almost all
of the CCR5
+ and CCR3
+CD4
+ T cells recruited to the lungs of
patients with active TB express the memory T-cell phenotype and
that the majority may have been recently activated [21]. CD69 is a
membrane molecule transiently expressed on activated lympho-
cytes, and its selective expression in inflammatory infiltrates
probably suggests that it plays a role in the pathogenesis of
inflammatory diseases [22]. Previous studies have also demon-
strated the usefulness of the determination of CD69 on CD4
+ T
cells after in vitro stimulation with tuberculin as a rapid indicator
of immune sensitization against MTB [23,24]. However, these
studies did not directly assess the function of CD69
+ cells.
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discrepancy of phenotypes among pleural fluid cells (PFCs) from
patients with TBP, PBMCs from TB patients and normal donors.
We found a significant increase in CD69 expression on CD4
+ T
cells in PFCs. Importantly, CD4
+CD69
+ cells were mostly Th1
cells specific for ESAT-6 and CFP-10 peptides. The phenotypic
and functional analysis of CD69-expressing cells strongly suggested
that CD69 could be a useful marker for the identification or
enrichment of antigen specific Th1 cells at local sites following
MTB infection. CD69 may be useful for diagnostic procedures,
including specific immune monitoring during TB infection or after
vaccination, as well as for therapeutic applications such as targeted
adoptive Th1 cell therapies.
Results
Significantly higher expression of CD69 on CD4
+ T cells in
PFCs from patients with TBP than in PBMCs from TB
patients and healthy donors without any stimulation
Our initial experiments assessed the surface expression of CD69
on CD4
+ T cells from PFCs of patients with TBP and PBMCs
from TB patients (PTB) and healthy donors (HD). As expected,
without any stimulation, a significantly higher level of CD69
expression was observed on CD4
+ T cells from PFCs of TBP
patients than on PBMCs from either PTB or HD (Fig. 1A and B,
P,0.001). Moreover, higher levels of CD69 expression
(11.60%611.93%, mean 6 SD) on CD4
+ T cells were observed
in 78% of the PFCs from individuals with TBP than on the
PBMCs of PTB or HD (1.48%61.60% for healthy donors and
1.38%61.68% for TB patients, mean 6 SD). No significant
difference in CD69 expression was observed on PBMCs from PTB
and from HD (Fig 1B, P=ns). In addition, we also demonstrated
that CD4
+CD69
+ T cells expressed significantly higher levels of
HLA-DR than CD4
+CD69
2 T cells, a molecule which is usually
induced on CD4
+ T cells after activation (Fig 1C and D,
P,0.001). Unexpectedly, no significant difference was observed in
the expression of CD25, another activation marker, which is
usually temporally expressed on activated T cells or constitutively
expressed on regulatory T cells (Fig 1C and D, P=ns).
Significantly higher expression of T-bet and IL-12Rb2b y
CD4
+CD69
+ T cells than by CD4
+CD69
2 T cells
In order to confirm whether CD4
+CD69
+ T cells in PFCs were
Th1 cells, we further evaluated the expression of T-bet, an
important transcription factor specific for Th1 cells. The results
showed that more than 90% of CD4
+CD69
+ T cells and about
57.24% of CD4
+CD69
2 T cells expressed T-bet (Fig 2A). The
expression of T-bet on CD4
+CD69
+ T cells was significantly
higher than that on CD4
+CD69
2 T cells (Fig 2B, P,0.01). We
next examined the expression of IL-12Rb2, another marker highly
specific for differentiated Th1 cells. Similar to the results obtained
for T-bet expression, the majority of CD4
+CD69
+ T cells
constitutively expressed IL-12Rb2 (Fig. 2A), and the expression
was significantly higher than that observed on CD4
+CD69
2 T
cells (Fig 2C, P,0.05 ), further confirming that the CD4
+CD69
+ T
cell subset was highly enriched for Th1 cells.
ESAT-6 and CFP-10 peptides-specific Th1 cells were
preferentially enriched within CD4
+CD69
+ T cells
Because CD4
+CD69
+ T cells were predominantly Th1 cells,
we aimed to examine whether direct ex vivo evaluation of surface
expression of CD69 without in vitro upregulation permits direct
assessment of MTB-specific Th1 cells. Our initial experiments
indicated that stimulation of PFCs with ESAT-6 and CFP-10
peptides resulted in increased surface CD69 expression that is
difficult to elucidate (Data not shown). Short-term stimulation of
these cells includes incubation with secretion inhibitory brefeldin
A (BFA), which can block the transport of newly synthesized
CD69 molecules to the cell surface and thus allows for the direct
assessment of the relationship between in vivo CD69 expression
and cytokine production. After culturing PFCs with ESAT-6/
CFP-10 peptides and BFA, we analyzed the production of Th1
cytokines by intracellular cytokine staining and polychromatic
flow cytometry. As shown in Fig 3A and B, CD4
+CD69
+ T cells
produced greater amounts of IFN-c, IL-2 and TNF-a than did
CD4
+CD69
2 T cells. Statistical results demonstrated that the
percentages of IFN-c,I L - 2o rT N F - a-producing CD4
+CD69
+ T
cells were significantly higher than those for CD4
+CD69
2 T cells
(P,0.001, Fig 3C). In order to further confirm that the responses
of T cells were specific for MTB, we also stimulated PFCs from
tuberculous pleurisy patients with other irrelevant antigens such
as SARS-CoV S peptides (STFFSTFKCYGVSATKL) and
(NFSQILPDPLKPTK RSFI) as well as hepatitis B virus surface
antigen (HBsAg). We found that these irrelevant antigens could
not induce the production of IFN-c, IL-2 and TNF-a by neither
CD4
+CD69
+ nor CD4
+CD69
2 T cells. However, following
stimulation with MTB-specific peptides of ESAT-6/CFP-10,
CD4
+CD69
+ T cells from the same patients expressed high levels
of IFN-c, IL-2 and TNF-a (data not shown).
Significant positive correlation between the percentages
of CD69-expressing CD4
+ T cells and polyfunctional T
cells
It has been suggested that T cells simultaneously producing
IFN-c, IL-2 and TNF-a are associated with protective immunity
and concomitant beneficial outcomes, at least in chronic viral
infections such as HIV. We therefore compared the expression of
IFN-c, IL-2 and TNF-a in CD4
+CD69
+, CD4
+CD69
2 and total
CD4
+ T cells after short-term in vitro stimulation with ESAT-6/
CFP-10 peptides. We showed that CD4
+CD69
+ and CD4
+CD69
2
T cells concurrently and individually produced IFN-c, IL-2 and
TNF-a (Fig 4A, B). This assay also identified cells that expressed
CD69 but lacked expression of any cytokine measured (as
evidenced by a subset of CD4
+CD69
+IFN-c
2IL-2
2TNF-a
2 cells).
These cells probably contained other effector functions, for
example, the secretion of MIP-1b or other cytokines. The total
antigen-specific responses were defined as the percentages of T
cells expressing any combination of IFN-c, IL-2 or TNF-a, and
thus, seven distinct functional populations could be delineated
(IFN-c/IL-2/TNF-a triple expressers; IFN-c/IL-2, IFN-c/TNF-a
or TNF-a/IL-2 double expressers; or IFN-c, IL-2 or TNF-a single
expressers). Interestingly, polyfunctional T cells (IFN-c/IL-2/
TNF-a triple expressers) dominated the CD4
+CD69
+ T cell
response. However, frequencies of T cells producing only TNF-a
were the highest when analyzing the distribution of the seven
subsets within either the CD4
+CD69
2 population or all CD4
+ T
cells (Fig 4C, D). The percentages of double expressers were
similar within CD4
+CD69
+, CD4
+CD69
2 and total CD4
+ T cells.
Our results demonstrated that total MTB-specific CD4
+ T cells
were not dominated by polyfunctional T cells. However,
polyfunctional T cells were primarily enriched within
CD4
+CD69
+ T cells. We further analyzed the correlation between
the percentages of CD69-expressing CD4
+ T cells and polyfunc-
tional T cells. Interestingly, significant positive correlation between
CD4
+CD69
+ T cells and polyfunctional T cells was observed
(Fig 4E, p=0.0003).
M.tuberculosis-Specific Polyfunctional Th1 Cells
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+CD69
+ T cells were mostly effector memory T cells
We next investigated the phenotype of CD4
+CD69
+ T cells relating
to naı ¨ve/memory markers. As shown in Fig 5A, CD4
+CD69
+ T cells
were predominantly CD45RO
+CD45RA
2, thereby exhibiting a
memory cell phenotype. In contrast, CD4
+CD69
2 T cells contained
significantly higher percentages of CD45RA
+and lower percentages of
CD45RO
+ cells than did CD4
+CD69
+ Tc e l l s .M o r e o v e r ,w ea l s o
examined the expression of CD127 and CD27 and found that
CD4
+CD69
+T cells had significantly lower expression of both markers
(Fig 5B). To further validate whether MTB-specific CD4
+CD69
+ T
cells were memory cells, we tested the phenotype of IFN-c-secreting
CD4
+CD69
+ T cells by assessing typical memory T cell markers. As
expected, the majority of CD4
+CD69
+IFN-c
+ T cells displayed a
CD45RA
2CCR7
2CD62L
2CD27
2 effector memory cell phenotype
(Fig 5C), suggesting that these cells were capable of producing multiple
cytokines quickly at local sites.
Figure 1. Significantly higher expression of CD69 on CD4
+ T cells in PFCs from patients with TBP without any stimulation.
(A) Representative expression of CD69 on CD4
+ T cells was determined by FACS in PBMCs from healthy donors (HD), patients with pulmonary
tuberculosis (PTB) and pleural fluid cells from patients with TBP (PFCs). (B) Summary data of CD69 expression on HD (n=22), PTB (n=21) and PFCs
(n=50). Each symbol represents a value from a single donor. Horizontal lines denote mean expression. (C) Expression of CD25 and HLA-DR on
CD4
+CD69
+ and CD4
+CD69
2 T cells. The expression of each marker within the CD4
+CD69
+ and CD4
+CD69
2 T cell subsets is shown by the dotted line.
(D) Average value of CD25 and HLA-DR expression on CD4
+CD69
+ and CD4
+CD69
2 T cells from six independent experiments is demonstrated. ns, not
significant.
doi:10.1371/journal.pone.0023700.g001
M.tuberculosis-Specific Polyfunctional Th1 Cells
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23700Figure 2. Expression of T-bet and IL-12Rb2 by CD4
+CD69
+ and CD4
+CD69
2 T cells as assessed by direct ex vivo staining.
(A) Expression of T-bet and IL-12Rb2 was evaluated on CD4
+CD69
+ and CD4
+CD69
2 T cells by flow cytometry. (B, C) Summary data of T-bet (B) and
IL-12Rb2 (C) expression on CD4
+CD69
+ and CD4
+CD69
2 T cells derived from five independent experiments are represented.
doi:10.1371/journal.pone.0023700.g002
Figure 3. Th1 cytokine-producing cells were enriched within CD4
+CD69
+ T cells. (A, B) PFCs were stimulated with ESAT-6/CFP-10 peptides
(P1-P6), anti-CD28mAbs, anti-CD49d mAbs and BFA for eight hours. Cells were gated on CD4
+CD69
+ and CD4
+CD69
2 T cell populations.
Representative expression of IFN-c, IL-2 and TNF-a on CD4
+CD69
+ (A) and CD4
+CD69
2 T cells (B) is shown. The numbers in each quadrant represent
the percentages of positive cells in gated T cells. (C) Summary data of the frequency of cytokine-producing CD4
+CD69
+ and CD4
+CD69
2 T cells
(n=14). Horizontal lines represent means 6 SD.
doi:10.1371/journal.pone.0023700.g003
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We further investigated whether purified CD4
+CD69
+ T cells,
stained by fluorescently labeled monoclonal antibody and sorted
by flow cytometry, would be compatible with assays that required
live cells. We first purified CD4
+ T cells and CD14
+ cells by
positive selection with microbeads. Thereafter, CD4
+CD69
+ and
CD4
+CD69
2 T cell fractions were obtained by flow cytometry-
based cell sorting (Fig 6A). We then cocultured CD4
+CD69
+ or
CD4
+CD69
2 T cells with CD14
+ cells (as antigen-presenting cells)
in the presence of ESAT-6/CFP-10 peptides (P1–P6) and
measured the production of Th1 cytokines. Notably, considerable
levels of IFN-c and IL-2 were produced by CD4
+CD69
+ T cells,
whereas little was observed from the CD4
+CD69
2 fractions.
However, TNF-a production was readily detected in unstimulated
cells, and significantly higher TNF-a was measured following
stimulation of the CD4
+CD69
+ fractions (Fig 6B). Moreover,
significantly higher levels of IFN-c, IL-2 and TNF-a were
produced by CD4
+CD69
+ cells than by CD4
+CD69
2 T cells
(P,0.001, Fig 6B). We also assessed percentages of Th1 cytokine-
producing cells by flow cytometry. As expected, CD4
+CD69
+ T
cells were highly enriched for IFN-c, IL-2 and TNF-a production
compared with CD4
+CD69
2 cells (Fig 6C–E). Thus, CD69
expression provides a means to identify the vast majority of
antigen-specific CD4
+ T cells, regardless of the type of cytokine
measured. Importantly, our assay conditions based on the CD69
coculture assay retained the ability of cells to secrete multiple
cytokines.
CD4
+CD25
+ T cells inhibit production of Th1 cytokines by
CD4
+CD69
+ T cells
In order to examine whether CD4
+CD25
+ Treg cells could
directly inhibit cytokine production by CD4
+CD69
+ T cells, we
sorted CD4
+CD69
+ and CD4
+CD25
+ T cells by flow cytometry
(Fig 7A). In order to further confirm that CD4
+CD25
+ T cells
were regulatory T cells, we found that the majority of
CD4
+CD25
+ T cells (.95%) expressed Foxp3(Data not shown),
the specific marker for this subset. We further confirmed this
observation by incubation of sorted CD4
+CD69
+ or CD4
+CD25
+
T cells with CD14
+ T cells, respectively. The result demonstrated
that neither IFN-c nor TNF-a was produced by the CD4
+CD25
+
T cells, whereas CD4
+CD69
+ T cells produced large amounts of
IFN-c and TNF-a upon coculture (Fig 7B), confirming that
CD4
+CD25
+ T cells were hyporesponsive and represented
regulatory T cells. We then cocultured CD4
+CD69
+ with
CD4
+CD25
+ T cells at different ratios in the presence of CD14
+
cells. CD4
+CD69
+ cells stimulated with ESAT-6/CFP-10 peptides
(P1–P6) produced considerably greater amounts of Th1 cytokines
compared with unstimulated cells. The addition of CD4
+CD25
+ T
cells into cultures resulted in the inhibition of IFN-c, IL-2 and
TNF-a production in a dose-dependent manner (Fig 7C–E).
Figure 4. Significantly positive correlation between the percentages of CD4
+CD69
+ T cells and polyfunctional T cells. (A) Cells were
gated on CD4
+CD69
+IFN-c
+ and CD4
+CD69
+IFN-c
2 cells, respectively. Representative expression of TNF-a and IL-2 within gated cells is shown.
(B) Cells were gated on CD4
+CD69
2IFN-c
+ and CD4
+CD69
2IFN-c
2 cells, respectively. The representative expression of TNF-a and IL-2 within gated
cells is shown. The numbers in each quadrant represent the percentages of positive cells in gated T cells. (C) The average frequencies of CD4
+CD69
+,
CD4
+CD69
2 and CD4
+ T cells expressing each of the seven combinations of IFN-c, IL-2 and TNF-a from twenty-two independent experiments are
demonstrated. The mean and SEM are shown. (D) Responses are grouped according to the number of functions. The pie charts summarize the
fractions of single (1+ blank), double (2+ gray), and triple (3+ black) producers of IFN-c, IL-2 and TNF-a within the CD4
+CD69
+, CD4
+CD69
2 and CD4
+ T
cell subsets from twenty-two independent experiments. (E) Significant positive correlation between CD4
+CD69
+ T cells and polyfunctional T cells
(p=0.0003, n=22).
doi:10.1371/journal.pone.0023700.g004
M.tuberculosis-Specific Polyfunctional Th1 Cells
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PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23700Figure 5. Effector memory CD4
+CD69
+ T cells produced IFN-c in response to MTB-specific peptides. (A) PFCs were stained with CD4,
CD69, CD45RA, CD45RO, CD127 and CD27. The expression of each marker within CD4
+CD69
+ and CD4
+CD69
2 T cells was evaluated by FACS. Isotype
controls are shown in gray and the expression of each marker is shown by dotted lines. (B) Mean value of expression of each marker on CD4
+CD69
+
and CD4
+CD69
2 T cells. Differences between groups were assessed by the Wilcoxon matched pairs test (Two-tailed). (C) PFCs stimulated with P1-P6
were gated on CD4
+CD69
+IFN-c
+ and CD4
+CD69
+IFN-c
2 cells and analyzed for the expression of memory markers CD45RA, CCR7, CD62L and CD27,
as indicated. Upper panel represents the control. Lower panel represents the expression of each marker. CD4
+CD69
+IFN-c
+ T cells are shown in black,
whereas CD4
+CD69
+IFN-c
2 T cells are depicted in gray. The expression of each marker within CD4
+CD69
+IFN-c
+ T cells was overlaid with
CD4
+CD69
+IFN-c
2 T cells. The numbers in the quadrants indicate the percentage of cells among CD4
+CD69
+IFN-c
+ T cells. One representative result
from ten independent experiments with similar results is shown.
doi:10.1371/journal.pone.0023700.g005
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PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23700Overall, our assay conditions showed that CD4
+CD25
+ cells could
inhibit Th1 cytokine production by CD4
+CD69
+ T cells.
Discussion
Without treatment, tuberculous pleurisy (TBP) usually resolves
spontaneously [25] and thus is thought to be a useful model to
study the correlates of protective immune responses at the site of
infection[26,27]. Meanwhile, the diagnosis of TBP is difficult and
continues to pose clinical challenges. Currently, the two major
advances in the diagnosis of TBP have been pleural biopsies[4]
and adenosine deaminase (ADA) assessment in pleural fluid
[28,29]. The free (unstimulated) pleural fluid IFN-c assay is
another method established for the diagnosis of TBP[30].
However, both ADA and IFN-c are non-specific markers of
inflammation[30].
The detection of T cell responses specific for defined antigens is
essential for the evaluation of pathogenic or protective immunity
induced by infectious pathogens or vaccines. CD4
+ T cell
responses are commonly determined by the expression of various
cytokines, such as IFN-c, IL-2 and TNF-a for Th1 cells, after
short-term stimulation with specific antigens. The development of
IFN-c release assays (IGRAs) has emerged as an attractive
alternative to the tuberculin skin test for detection of latent TB
infections and might also contribute to assisting in the diagnosis of
TBP [31]. IGRAs are based on the principle that T cells of
individuals sensitized with TB antigens produce IFN-c when they
re-encounter highly MTB-specific antigens such as ESAT-6 and
CFP-10. However, this assay precludes further analysis because it
is lethal to cells. Moreover, the IGRAs are not recommended on
either the blood or the pleural fluid for the diagnosis of TBP [31].
Consistent with other studies, we found that the expression of
CD69 was significantly increased on CD4
+ T cells in PFCs from
patients with TBP [32]. We further demonstrated that the
majority of CD4
+CD69
+ cells were Th1 cells by analyzing
expression of the Th1 markers T-bet and IL-12Rb2. In order to
Figure 7. CD4
+CD25
+ cells inhibit the production of Th1 cytokines by sorted CD4
+CD69
+ T cells. (A) CD4
+CD25
+ and CD4
+CD69
+ cells
were sorted from purified CD4
+ T cells. (B) Production of IFN-c and TNF-a by sorted CD4
+CD69
+ and CD4
+CD25
+ cells in the presence of purified
CD14
+ T cells following stimulation with P1–P6. (C–E) Sorted CD4
+CD25
+ and CD4
+CD69
+ cells were cultured at different ratios and cocultured with
purified CD14
+ cells in the presence or absence of P1–P6. The supernatants were collected, and cytokine production was assessed by ELISA. One
representative result from three independent experiments with similar results is shown. Significant differences compared with incubation with P1–P6
in the absence of Tregs are indicated (*, not significant;**, P,0.05;***, P,0.001).
doi:10.1371/journal.pone.0023700.g007
Figure 6. Isolation of viable CD4
+CD69
+ and CD4
+CD69
2 T cells. (A) CD4
+CD69
+ and CD4
+CD69
2 cells were sorted from magnetic bead-
purified CD4
+ T cells. (B) Sorted CD4
+CD69
+ and CD4
+CD69
2 cells were cocultured with purified CD14
+ cells in the presence or absence of BCG or P1-
P6. Supernatants were collected and cytokine production was assessed by ELISA. Significant differences compared with CD4
+CD69
2 fractions are
indicated (***, P,0.001). (C, D) After stimulation for 8 hours, CD4
+ T cells were gated and the expression of Th1 cytokines by CD4
+CD69
+ and
CD4
+CD69
2 cells was analyzed. Numbers in the quadrants indicate percentages of cells among the CD4
+CD69
+ or CD4
+CD69
2 populations. (E) The
frequencies of IFN-c, IL-2 or TNF-a-producing CD4
+CD69
+ (closed circles) or CD4
+CD69
2 T cells (open circles, n=3–5) are demonstrated. Horizontal
lines represent mean value.
doi:10.1371/journal.pone.0023700.g006
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e23700further confirm that CD4
+CD69
+ cells were mostly MTB-specific
T cells, we performed intracellular cytokine staining. We noted
that stimulation of PFCs resulted in increased surface CD69
expression. We overcame this limitation by incubation with BFA
during short-term stimulation. Using this method, we were able to
directly assess the relationship between in vivo CD69 expression
and cytokine production. Using polychromatic flow cytometry, we
demonstrated for the first time that the majority of MTB specific
Th1 cytokine-producing cells were enriched within the
CD4
+CD69
+ subset, whereas CD4
+CD69
2 cells scarcely pro-
duced cytokines. In addition, PFCs from tuberculous pleurisy
patients were stimulated with SARS-CoV S peptides
(STFFSTFKCYGVSATKL) and (NFSQILPDPLKPTKRSFI) as
well as hepatitis B virus surface antigen (HBsAg). These irrelevant
antigens could not induce the production of IFN-c, IL-2 and TNF-
a by neither CD4
+CD69
+ nor CD4
+CD69
2 T cells. However,
following stimulation with MTB-specific peptides of ESAT-6/
CFP-10, CD4
+CD69
+ T cells from the same patients with
tuberculous pleurisy expressed high levels of IFN-c, IL-2 and
TNF-a, indicating that the response was MTB-specific. Most
importantly, the detection of CD69 is useful for the direct
identification of MTB-specific Th1 cells in vivo without further
stimulation.
T cells that produce multiple factors simultaneously are termed
polyfunctional T cells and have been shown to provide vaccine-
induced immunity and protection against disease progression in
HIV-1 infection[33,34]. In the present study, analysis of total
CD4
+ Th1 subpopulations indicated that the majority of Th1 cells
produced only one cytokine. However, polyfunctional CD4
+ T
cells simultaneously producing IFN-c, IL-2 and TNF-a dominated
the CD4
+CD69
+ T cell population, but the percentage of TNF-a
single expressers was higher in both the CD4
+CD69
2 and the total
CD4
+ T cell subsets compared with CD4
+CD69
2 cells. Our
results indicated that detection or isolation of CD69
+ T cells is a
good method for the identification or enrichment of polyfunctional
T cells. Interestingly, significant positive correlation was observed
between the percentages of CD69-expressing CD4
+ T cells and
polyfunctional T cells. Our results demonstrated for the first time
that the expression of CD69 may be a useful marker for the
definition of MTB-specific polyfunctional T cells in vivo. A
number of studies in humans suggested that polyfunctional T cells
may indeed be involved in mediating protection in TB[34–39].
However, it has also been indicated in the recent studies that
polyfunctional CD4
+ T cells may be a useful biomarker of active
TB and that polyfunctional responses are not associated with
protection against TB[40]. In the present study, we hypothesized
that the highly increased frequencies of CD69-expressing CD4
+ T
cells (polyfunctional T cells) in pleural fluid may be associated with
protection against TB and thus lead to the self-resolution tendency
of TBP.
A previous study has indicated that CD4
+CD69
+CD25
2 cells
represented a new subset of regulatory T cells in the tumor model
[41]. These CD4
+CD69
+CD25
2 cells are hyporesponsive and can
suppress proliferation of CD4
+ T cells in a cell-to-cell contact
manner. In our study, however, CD4
+CD69
+ T cells represented
effector or effector memory cells and quickly produced large
amounts of cytokines following short-term stimulation. Moreover,
we also assessed other markers (Foxp3 and CTLA-4) essential for
the suppressive function of regulatory T cells and found that these
molecules were not differentially expressed by CD4
+CD69
+ and
CD4
+CD69
2 T cells, further confirming that CD4
+CD69
+ T cells
were not regulatory T cells (data not shown). These differing
results were probably associated with discrepancies in local
circumstances, including cytokines, chemokines and antigen
presenting cells that differ between tumor and inflammation
contexts. Moreover, it remains to be determined if CD69 is
induced by the pleural fluid environment or if CD4
+CD69
+ T cells
are selectively recruited from the circulation.
Previous studies have indicated that CD4
+CD25
+ T cells can
inhibit antigen-specific T cell responses in TB patients[42–47].
However, none of these studies has isolated MTB-specific CD4
+ T
cells directly. In the present study, we purified viable CD4
+CD69
+
and CD4
+CD25
+ Treg cells directly and found that CD4
+CD25
+
Treg cells could inhibit cytokine production by CD4
+CD69
+ T
cells. In addition, our results clearly demonstrated that
CD4
+CD25
+ T cells were hyporesponsive and scarcely produced
cytokines following short-term stimulation, further confirming that
these cells were regulatory cells. In our previous studies, we have
demonstrated that the suppressive effect of Treg cells on IFN-c
production by CD4
+CD25
+ T cells[43] and cd T cells[48] was
mainly mediated via the release of IL-10 but not TGF-b.
In summary, we demonstrated that CD69 as a useful marker for
MTB-specific Th1 cells in PFCs from patients with TBP enabled a
direct ex vivo estimation of the quantity, as well as the quality, of
MTB-specific Th1 responses. The majority of CD4
+CD69
+ T cells
but not total CD4
+ T cells, were dominated by polyfunctional T
cells. Importantly, significantly positive correlation was observed
between CD69-expressing CD4
+ T cells and polyfunctional T
cells, suggesting that CD69 is a good marker for the identification
or enrichment of polyfunctional T cells in PFCs. Moreover,
isolation of live MTB-specific Th1 cells according to surface CD69
expression without any stimulation offers an opportunity for
further investigation.
Methods
Ethics Statement
Written informed consent was obtained from all patients and
healthy donors. Ethics approval for the present study was obtained
from the ethics committee of the Zhongshan School of Medicine,
Sun Yat-sen University (Guangzhou, China) and the Chest
Hospital of Guangzhou (Guangzhou, China).
Study participants
A total of fifty patients with tuberculous pleurisy (15 females and
35 males, range 18–71 years of age) were recruited from the Chest
Hospital of Guangzhou, China. Diagnosis of pleural effusion from
TB etiology was based on one of the following criteria: (i)
demonstration of MTB on pleural fluid smear (by the Ziehl-
Neelsen method); (ii) pleural fluid or pleural biopsy specimens
growing M. tuberculosis on Lowenstein-Jensen medium; or (iii)
histological evidence of caseating granuloma on biopsy specimens
of pleural tissue with positive staining for M. tuberculosis. Twenty-
one patients (10 females and 11 males, range 20 to 50 years of age)
with active pulmonary tuberculosis (culture-confirmed pulmonary
TB) were also included in this study. Patients who had been
previously diagnosed with HIV, HBV, or HCV or with a history of
autoimmune diseases were excluded from the study. None of the
patients was receiving MTB-related treatments at the time of the
study. Twenty-two healthy volunteers between the ages of 20 and
54 were recruited from Sun Yat-sen University.
Peptides, reagents and mAbs
For the detection of MTB-specific immune responses, we selected
six highly immunogenic and largely HLA-DR-restricted peptides.
Four peptides were derived from ESAT-6, and two were derived
from the CFP-10 protein of MTB. Synthetic peptides of 20 amino
a c i d s( a a )i nl e n g t hw e r eo b t a i n e df r o mS h e n z h e nH a n y u
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follows: P1, ESAT-61–20 (MTEQQWNFAGIEAAASAIQG); P2,
ESAT-631–50 (EGKQSLTKLAAAWGGSGSEA); P3, ESAT-661–80
(TATELNNALQNLARTISEAG); P4, ESAT-671–90 (NLARTI-
SEAGQAMASTEGNV); P5, CFP-1051–70 (AQAAVVRFQ
EAANKQKQELD) and P6, CFP-1071–90 (EISTNIRQAGVQYS-
RADEEQ). Freeze-dried BCG (Chengdu Institute of Biological
Products, Chengdu, China) was reconstituted in a 0.9% sodium
chloride solution to a concentration of 1 mg/mL prior to use.
Purified anti-CD28 (clone CD28.2) and anti-CD49d (clone 9F10)
mAbs were purchased from BD Biosciences (San Jose, CA). The
following mAbs were used for phenotypic and intracellular cytokine
analysis and were purchased from BD Biosciences (San Jose, CA,
USA): CD62L-PE (Dreg56), CCR7-PE (3D12), TNF-a-PE (Mab11),
CD69-PE (FN50), T-bet-PE (O4-46), Streptavidin-PE, CD45RA-
FITC (L48), CD25-FITC (M-A251), CD4-PerCP (L200), CD8-
Pecy7 (RPA-T8), CD69-Pecy7 (FN50), APC-IL-2 (MQ1-17H12),
purified rat anti-human CD212 (2B6/12b2), and isotype-matched
control antibodies. CD27-APC (O323) was obtained from Biolegend
(San Diego, CA). IFN-c-FITC (45.15) was purchased from Beckman
Coulter (Fullerton, CA). Biotin-SP-conjugated affinipure F(ab’)2
fragment donkey anti-rat IgG (H+L) was purchased from Jackso-
nImmunoResearch laboratories, Inc. (West Grove, PA).
Preparation of PFCs and PBMCs
PFCs were isolated by lysing erythrocytes using ammonium
chloride solution and resuspended to a final concentration of
2610
6 cells/mL in complete RPMI 1640 medium (Invitrogen,
Grand Island, NY) supplemented with 10% heat-inactivated fetal
calf serum (FCS; HyClone, Logan, UT), 100 U/mL penicillin,
100 mg/mL streptomycin, 2 mM L-glutamine, and 50 mM2 -
mercaptoethanol. Peripheral blood mononuclear cells (PBMCs)
were isolated by Ficoll-Hypaque gradient centrifugation of
heparinized venous blood obtained from healthy individuals or
TB patients.
Flow cytometry
For the detection of intracellular cytokines, cells were incubated
at a concentration of 2610
6 cells/mL with 1 mg/mL peptides plus
1 mg/mL anti-CD28 and 1 mg/mL anti-CD49d for 8 h in the
presence of brefeldin A (BFA, 10 mg/mL; Sigma-Aldrich, St Louis,
MO). For the detection of T-bet, surface markers were first stained
and cells were then fixed in 2% formaldehyde, permeabilized in
90% methanol and labeled with anti T-bet mAb. The expression
of IL-12Rb2 was detected by indirect immunofluorescence
analysis. Briefly, cells were incubated with mAb for IL-12Rb2,
followed by biotin-SP-conjugated anti-rat IgG F(ab’)2 fragments,
and were finally incubated with streptavidin-PE. All incubations
were performed at 4uC and cells were washed twice between
incubations. Flow cytometry was performed using BD FACSCa-
libur (BD Biosciences) or FACSAria II (BD Biosciences) and the
data were analyzed using FlowJo software (TreeStar, San Carlos,
CA).
Isolation of cell subsets
CD4
+ and CD14
+ cells were isolated from PFCs by positive
selection with anti-CD4 or anti-CD14 microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany). For isolation of
CD4
+CD69
+, CD4
+CD69
2 and CD4
+CD25
+ cells, purified
CD4
+ T cells were stained with PE-conjugated CD69 and
FITC-conjugated anti-CD25 and then sorted on a FACSAria II
high-speed cell sorter. The purity of cells, as assessed by flow
cytometry, was 95–97% for each cell subset.
Cell culture conditions
Purified CD4
+CD69
+, CD4
+CD69
2 or CD4
+ T cells were co-
cultured with purified CD14
+ cells (at ratio of 1:2 ) in the presence
or absence of BCG, ESAT-6 and CFP-10 peptides. After
48 hours, cell-free supernatants were collected and assessed for
IFN-c, IL-2 and TNF-a production by ELISA kits (BD Bioscience
Pharmingen). For the detection of intracellular cytokines, cells
were cultured for 8 hours and then subjected to flow cytometry
analysis. To examine the role of CD4
+CD25
+ cells in the
regulation of cytokine production by sorted CD4
+CD69
+ T cells,
purified CD4
+CD69
+ (Teff), CD14
+ cells and CD4
+CD25
+ cells
(Treg) were co-cultured in various ratios (Teff:Treg) in the
presence of ESAT-6 and CFP-10 peptides. Cell-free supernatants
were collected and assessed for IFN-c, IL-2 and TNF-a by ELISA.
Statistical analysis
The Wilcoxon matched pairs test (Two-tailed) was performed to
determine statistical differences between the groups using
GraphPad Prism software version 5. Inhibition of cytokine
production by CD4
+CD25
+ T cells was analyzed using the paired
Student’s t test. A value of p,0.05 was considered statistically
significant.
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